We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
+1.73%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$1.65B
AUM Growth
+$17.9M
Cap. Flow
+$2M
Cap. Flow %
0.12%
Top 10 Hldgs %
31.79%
Holding
624
New
85
Increased
145
Reduced
196
Closed
96

Sector Composition

Rank Sector Weight
1 Technology 14.21%
2 Healthcare 7%
3 Financials 4.95%
4 Communication Services 4.82%
5 Consumer Discretionary 3.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSBC icon
501
Old Second Bancorp
OSBC
$1.21B
$149K 0.01%
+12,200
New +$151K
TITN icon
502
Titan Machinery
TITN
$442M
$149K 0.01%
+10,400
New +$185K
TLYS icon
503
Tilly's
TLYS
$116M
$149K 0.01%
+15,800
New +$139K
MEC icon
504
Mayville Engineering Co
MEC
$775M
$148K 0.01%
+11,200
New +$150K
AMPY icon
505
Amplify Energy
AMPY
$171M
$145K 0.01%
23,500
-9,200
-28% -$52K
RJET
506
Republic Airways Holdings
RJET
$765M
$141K 0.01%
+1,393
New +$169K
SAMG icon
507
Silvercrest Asset Management
SAMG
$77.9M
$137K 0.01%
+11,100
New +$149K
SIEN
508
DELISTED
Sientra, Inc.
SIEN
$135K 0.01%
2,080
-420
-17% -$26.7K
APYX icon
509
Apyx Medical
APYX
$161M
$128K 0.01%
18,922
COLL icon
510
Collegium Pharmaceutical
COLL
$1.15B
$126K 0.01%
11,000
SBOW
511
DELISTED
SilverBow Resources, Inc.
SBOW
$126K 0.01%
+13,030
New +$134K
GNE icon
512
Genie Energy
GNE
$384M
$122K 0.01%
16,300
-3,200
-16% -$27.9K
RCUS icon
513
Arcus Biosciences
RCUS
$3.74B
$121K 0.01%
13,300
-25,000
-65% -$201K
IDT icon
514
IDT Corp
IDT
$1.56B
$119K 0.01%
11,300
-5,800
-34% -$57.9K
SCYX icon
515
SCYNEXIS
SCYX
$39.3M
$111K 0.01%
1,303
-322
-20% -$29.4K
ARDX icon
516
Ardelyx
ARDX
$1.27B
$109K 0.01%
23,141
NPTN
517
DELISTED
NEOPHOTONICS CORP
NPTN
$106K 0.01%
+17,395
New +$97.8K
PRCP
518
DELISTED
Perceptron Inc
PRCP
$92K 0.01%
+19,100
New +$86K
ASPN icon
519
Aspen Aerogels
ASPN
$428M
$91K 0.01%
+15,300
New +$97.3K
CRWS icon
520
Crown Crafts
CRWS
$32M
$78K ﹤0.01%
+12,400
New +$62.1K
ARAY icon
521
Accuray
ARAY
$28.3M
$76K ﹤0.01%
27,400
JNCE
522
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$76K ﹤0.01%
22,800
CPIX icon
523
Cumberland Pharmaceuticals
CPIX
$105M
$70K ﹤0.01%
11,816
-2,700
-19% -$15K
ARC
524
DELISTED
ARC Document Solutions, Inc.
ARC
$68K ﹤0.01%
+50,030
New +$80.6K
LAB icon
525
Standard BioTools
LAB
$343M
$59K ﹤0.01%
+12,800
New +$101K

Similar funds

Bailard's Q3 2019 Portfolio in Review

As of Q3 2019, Bailard held 624 positions worth $1.65B, up 1.1% from $1.64B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bailard's Q3 2019 filing shows 85 new, 145 increased, 196 reduced and 96 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 504,999 shares worth $64.4M. The largest sale was Invesco QQQ Trust, an estimated $59.9M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Bailard's largest Q3 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 504,999 shares worth $64.4M.
  • Bailard added most to iShares National Muni Bond ETF in Q3 2019, an estimated $11M increase.
  • Bailard's biggest Q3 2019 reduction was Invesco QQQ Trust, cutting an estimated $59.9M.
  • Bailard fully exited Vanguard Total Bond Market in Q3 2019, selling an estimated $57.1M.
  • Bailard's ten largest holdings make up 32% of its $1.65B portfolio in Q3 2019.
  • Bailard opened 85 new positions and closed 96 in Q3 2019.
  • Bailard's portfolio value rose 1.1% quarter-over-quarter to $1.65B.

Based on Bailard's 13F filing for Q3 2019, filed 18 Oct 2019.